Welcome to LookChem.com Sign In|Join Free
  • or
ETHYL 2-(2-FORMYLPHENOXY)ACETATE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

41873-61-4

Post Buying Request

41873-61-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41873-61-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 41873-61-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,8,7 and 3 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 41873-61:
(7*4)+(6*1)+(5*8)+(4*7)+(3*3)+(2*6)+(1*1)=124
124 % 10 = 4
So 41873-61-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O4/c1-2-14-11(13)8-15-10-6-4-3-5-9(10)7-12/h3-7H,2,8H2,1H3

41873-61-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50286)  Ethyl (2-formylphenoxy)acetate, 99%   

  • 41873-61-4

  • 250mg

  • 194.0CNY

  • Detail
  • Alfa Aesar

  • (H50286)  Ethyl (2-formylphenoxy)acetate, 99%   

  • 41873-61-4

  • 1g

  • 485.0CNY

  • Detail
  • Alfa Aesar

  • (H50286)  Ethyl (2-formylphenoxy)acetate, 99%   

  • 41873-61-4

  • 5g

  • 1795.0CNY

  • Detail

41873-61-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name ETHYL 2-(2-FORMYLPHENOXY)ACETATE

1.2 Other means of identification

Product number -
Other names ethylformylphenoxyacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41873-61-4 SDS

41873-61-4Synthetic route

salicylaldehyde
90-02-8

salicylaldehyde

ethyl bromoacetate
105-36-2

ethyl bromoacetate

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
With potassium carbonate In acetone for 20h; Heating;98%
With potassium carbonate In acetone Heating;88%
Stage #1: salicylaldehyde With potassium carbonate In acetone at 20℃; for 0.0833333h; Inert atmosphere;
Stage #2: ethyl bromoacetate In acetone for 4h; Reflux; Inert atmosphere;
86%
ethanol
64-17-5

ethanol

2-Formylphenoxyacetic acid
6280-80-4

2-Formylphenoxyacetic acid

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
With aluminum potassium sulfate dodecahydrate In neat (no solvent) at 80℃; for 12h; Time; Temperature; Green chemistry;92%
With sulfuric acid for 20h; Heating;66%
With potash alum In water at 80℃; for 12h;25 g
salicylaldehyde
90-02-8

salicylaldehyde

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
Stage #1: salicylaldehyde With potassium carbonate; sodium iodide In acetonitrile for 0.5h; Reflux; Inert atmosphere;
Stage #2: chloroacetic acid ethyl ester In acetonitrile for 6h; Reflux; Inert atmosphere;
75%
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide for 1h; Heating;27%
bromoethyl acetate
927-68-4

bromoethyl acetate

salicylaldehyde
90-02-8

salicylaldehyde

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; for 5h;72%
2-methyl-benzyl alcohol
89-95-2

2-methyl-benzyl alcohol

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 92 - 96℃; for 2h; Substitution;60%
With tetrabutylammomium bromide; potassium carbonate at 70℃; for 0.0833333h; microwave irradiation;
ethyl 2-<2-<(ethoxycarbonyl)methoxy>phenoxy>acetate
52376-09-7

ethyl 2-<2-<(ethoxycarbonyl)methoxy>phenoxy>acetate

A

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

B

1,2-Phenylendioxy-diessigsaeureethyl,methylester

1,2-Phenylendioxy-diessigsaeureethyl,methylester

Conditions
ConditionsYield
With di-tert-butyl peroxide In various solvent(s) at 150℃; for 14h;A 56 % Turnov.
B 6 % Turnov.
With di-tert-butyl peroxide In various solvent(s) at 150℃; for 14h; Product distribution; Mechanism; influence of the reaction-temp. (other temp.: 60 deg C) -> other products;A 56 % Turnov.
B 6 % Turnov.
2-methyl-benzyl alcohol
89-95-2

2-methyl-benzyl alcohol

ethyl bromoacetate
105-36-2

ethyl bromoacetate

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
Stage #1: 2-methyl-benzyl alcohol With potassium hydroxide In methanol at 50℃; for 0.5h;
Stage #2: ethyl bromoacetate In methanol; N,N-dimethyl-formamide at 0 - 25℃;
concentrated H2 SO4

concentrated H2 SO4

2-Formylphenoxyacetic acid
6280-80-4

2-Formylphenoxyacetic acid

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
In ethanol; toluene9.1 g (95%)
salicylaldehyde
90-02-8

salicylaldehyde

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / water / 3 h / Reflux
2: aluminum potassium sulfate dodecahydrate / 12 h / Reflux; Green chemistry
View Scheme
Multi-step reaction with 2 steps
1: sodium hydroxide / water / 3 h / 0 - 5 °C / Reflux
2: potash alum / water / 12 h / 80 °C
View Scheme
indole
120-72-9

indole

ethanol
64-17-5

ethanol

2-Formylphenoxyacetic acid
6280-80-4

2-Formylphenoxyacetic acid

A

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

B

2-{2-[bis(1H-indol-3-yl)methyl]phenoxy}acetic acid
486442-77-7

2-{2-[bis(1H-indol-3-yl)methyl]phenoxy}acetic acid

C

ethyl 2-[2-{bis(1H-indol-3-yl)methyl}phenoxy]acetate
654636-49-4

ethyl 2-[2-{bis(1H-indol-3-yl)methyl}phenoxy]acetate

Conditions
ConditionsYield
With aluminum potassium sulfate dodecahydrate for 12h; Reflux; Green chemistry;
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

ethyl 2-[2-(hydroxymethyl)phenoxy]acetate
111080-48-9

ethyl 2-[2-(hydroxymethyl)phenoxy]acetate

Conditions
ConditionsYield
With sodium tetrahydroborate; sodium ethanolate In ethanol 1.) 0-5 deg C; 2.) below 8 deg C, 3.75 h;100%
With sodium tetrahydroborate In methanol at -5 - 0℃; for 0.25h;95%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

ethyl coumarilate
3199-61-9

ethyl coumarilate

Conditions
ConditionsYield
With P(MeNCH2CH2)3N In ethanol at 70℃; for 3h;99%
With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 3h;
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

anthranilic acid amide
28144-70-9

anthranilic acid amide

ethyl 2-[2-(4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)phenoxy]acetate

ethyl 2-[2-(4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)phenoxy]acetate

Conditions
ConditionsYield
With yttrium(lll) nitrate hexahydrate In acetonitrile at 20℃; for 14h;96%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

3-phenyl-2-(phenylimino)-1,3-thiazolidin-4-one
790-04-5

3-phenyl-2-(phenylimino)-1,3-thiazolidin-4-one

ethyl 2-(2-((4-oxo-3-phenyl-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

ethyl 2-(2-((4-oxo-3-phenyl-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

Conditions
ConditionsYield
With piperidine In ethanol at 60℃; for 8h;95%
isopropyl acetoacetate
542-08-5

isopropyl acetoacetate

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

2,6-Dimethyl-4-(2-ethoxycarbonylmethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid diisopropyl ester

2,6-Dimethyl-4-(2-ethoxycarbonylmethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid diisopropyl ester

Conditions
ConditionsYield
With ammonium acetate In pyridine90%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

(Z)-3-(2-hydroxyethyl)-2-(phenylimino)thiazolidin-4-one

(Z)-3-(2-hydroxyethyl)-2-(phenylimino)thiazolidin-4-one

ethyl 2-(2-((Z)-((Z)-3-(2-hydroxyethyl)-4-oxo-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

ethyl 2-(2-((Z)-((Z)-3-(2-hydroxyethyl)-4-oxo-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

Conditions
ConditionsYield
With piperidine In ethanol at 60℃;86%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

(2S,3S)-3-(4-bromophenyl)-6-methyl-1-phenylhept-5-en-2-ol

(2S,3S)-3-(4-bromophenyl)-6-methyl-1-phenylhept-5-en-2-ol

ethyl 2-{2-[(2R,3S,5S,6R)-6-benzyl-5-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl]phenoxy}acetate

ethyl 2-{2-[(2R,3S,5S,6R)-6-benzyl-5-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl]phenoxy}acetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In toluene at 0℃; for 2.16667h; stereoselective reaction;85%
2-methyl-1H-indole
95-20-5

2-methyl-1H-indole

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

ethyl 2-[2-{bis(2-methyl-1H-indol-3-yl)methyl}phenoxy]acetate
1415995-53-7

ethyl 2-[2-{bis(2-methyl-1H-indol-3-yl)methyl}phenoxy]acetate

Conditions
ConditionsYield
With potassium titanium oxalate dehydrate In neat (no solvent) at 80℃; for 0.5h; Temperature;84%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

ethylenediamine
107-15-3

ethylenediamine

C24H28N2O6
138224-46-1

C24H28N2O6

Conditions
ConditionsYield
In ethanol for 3h; Reflux;83%
indole
120-72-9

indole

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

ethyl 2-[2-{bis(1H-indol-3-yl)methyl}phenoxy]acetate
654636-49-4

ethyl 2-[2-{bis(1H-indol-3-yl)methyl}phenoxy]acetate

Conditions
ConditionsYield
With potassium titanium oxalate dehydrate In neat (no solvent) at 80℃; for 0.75h; Temperature;83%
With acetic acid In water at 80℃;
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

dimedone
126-81-8

dimedone

ethyl 2-[2-(3,3,6,6-tetramethyl-1,8-dioxo-2,3,4,5,6,7,8,9-octahydro-1H-xanthen-9-yl)phenoxy]acetate
1552309-39-3

ethyl 2-[2-(3,3,6,6-tetramethyl-1,8-dioxo-2,3,4,5,6,7,8,9-octahydro-1H-xanthen-9-yl)phenoxy]acetate

Conditions
ConditionsYield
In water at 80℃; for 0.166667h;82%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

(2S,3R)-3-(4-bromophenyl)-6-methyl-1-phenylhept-5-en-2-ol

(2S,3R)-3-(4-bromophenyl)-6-methyl-1-phenylhept-5-en-2-ol

ethyl 2-{2-[(2R,3S,5R,6R)-6-benzyl-5-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl]phenoxy}acetate

ethyl 2-{2-[(2R,3S,5R,6R)-6-benzyl-5-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-yl]phenoxy}acetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In toluene at 0℃; for 2.16667h; stereoselective reaction;82%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

C28H28N2O6
1370036-70-6

C28H28N2O6

Conditions
ConditionsYield
In ethanol for 3h; Reflux;79%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

3,4-Dihydro-4-oxo-1,2-benzoxathiin-2,2-dioxid
49670-47-5

3,4-Dihydro-4-oxo-1,2-benzoxathiin-2,2-dioxid

malononitrile
109-77-3

malononitrile

C22H18N2O7S

C22H18N2O7S

Conditions
ConditionsYield
With triethylamine In ethanol for 1h; Reflux;79%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

syn-3-(4-bromophenyl)-5-methyl-1-phenylhex-5-en-2-ol

syn-3-(4-bromophenyl)-5-methyl-1-phenylhex-5-en-2-ol

ethyl 2-{2-[rel-(2S,3R,4R,5S)-5-benzyl-4-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydrofuran-2-yl]phenoxy}acetate

ethyl 2-{2-[rel-(2S,3R,4R,5S)-5-benzyl-4-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydrofuran-2-yl]phenoxy}acetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In toluene stereoselective reaction;78%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

(Z)-3-(3-hydroxypropyl)-2-(phenylimino)thiazolidin-4-one

(Z)-3-(3-hydroxypropyl)-2-(phenylimino)thiazolidin-4-one

ethyl 2-(2-((Z)-((Z)-3-(3-hydroxypropyl)-4-oxo-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

ethyl 2-(2-((Z)-((Z)-3-(3-hydroxypropyl)-4-oxo-2-(phenylimino)thiazolidin-5-ylidene)methyl)phenoxy)acetate

Conditions
ConditionsYield
With piperidine In ethanol at 60℃;77%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

benzylamine
100-46-9

benzylamine

N-benzyl-2-(2-formylphenoxy)acetamide

N-benzyl-2-(2-formylphenoxy)acetamide

Conditions
ConditionsYield
With graphene oxide In neat (no solvent) at 100℃; for 24h; Sealed tube;76%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

4-(2-ethoxycarbonylmethoxy-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester
51336-29-9

4-(2-ethoxycarbonylmethoxy-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester

Conditions
ConditionsYield
With ammonium acetate In pyridine75%
isatoic anhydride
118-48-9

isatoic anhydride

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

para-methylbenzylamine
104-84-7

para-methylbenzylamine

{2-[3-(4-methylbenzyl)-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl]phenoxy}acetic acid ethyl ester

{2-[3-(4-methylbenzyl)-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl]phenoxy}acetic acid ethyl ester

Conditions
ConditionsYield
With chitosan nanoparticles grafted on multi-wall carbon nanotubes (at) Fe3O4 In water Reflux; Green chemistry;75%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

anti-3-(4-bromophenyl)-5-methyl-1-phenylhex-5-en-2-ol

anti-3-(4-bromophenyl)-5-methyl-1-phenylhex-5-en-2-ol

ethyl 2-{2-[rel-(2S,3R,4S,5S)-5-benzyl-4-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydrofuran-2-yl]phenoxy}acetate

ethyl 2-{2-[rel-(2S,3R,4S,5S)-5-benzyl-4-(4-bromophenyl)-3-(prop-1-en-2-yl)tetrahydrofuran-2-yl]phenoxy}acetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In toluene stereoselective reaction;75%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

(4-oxo-3-p-tolyl-3,4-dihydro-quinazolin-2-ylsulfanyl)-acetic acid hydrazine
37029-36-0

(4-oxo-3-p-tolyl-3,4-dihydro-quinazolin-2-ylsulfanyl)-acetic acid hydrazine

ethyl (2-(2-((3-p-toluyl-4-oxo-3,4-dihydroquinazolin-2-yl)sulfanyl)acetylhydrazinylidene)methylphenoxy)acetate
1547192-82-4

ethyl (2-(2-((3-p-toluyl-4-oxo-3,4-dihydroquinazolin-2-yl)sulfanyl)acetylhydrazinylidene)methylphenoxy)acetate

Conditions
ConditionsYield
With sulfuric acid In ethanol for 4h; Reflux;72%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

2-Formylphenoxyacetic acid
6280-80-4

2-Formylphenoxyacetic acid

Conditions
ConditionsYield
With water; trifluoroacetic acid at 0℃; Reflux;63%
With sodium hydroxide In methanol; water for 0.5h; Heating;
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

2-O-(ethoxycarbonylmethyl)benzoic acid
108807-15-4

2-O-(ethoxycarbonylmethyl)benzoic acid

Conditions
ConditionsYield
With potassium bromate In water; acetic acid; acetone for 0.5h; Heating;50%
ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

6-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile

6-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile

(E)-2-(2-(2-(5-cyano-6-oxo-2-thioxo-1,2,3,6-tetrahydropyrimidin-4-yl)vinyl)phenoxy)acetic acid

(E)-2-(2-(2-(5-cyano-6-oxo-2-thioxo-1,2,3,6-tetrahydropyrimidin-4-yl)vinyl)phenoxy)acetic acid

Conditions
ConditionsYield
Stage #1: ethyl (2-formylphenoxy)acetate; 6-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile With piperidine In butan-1-ol Reflux; Inert atmosphere;
Stage #2: With sodium hydroxide at 20℃; for 6h; Inert atmosphere;
43%
pyrrole
109-97-7

pyrrole

ethyl (2-formylphenoxy)acetate
41873-61-4

ethyl (2-formylphenoxy)acetate

5,10,15,20-tetrakis<2-(ethoxycarbonylmethoxy)phenyl>porphyrin
127812-11-7

5,10,15,20-tetrakis<2-(ethoxycarbonylmethoxy)phenyl>porphyrin

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In dichloromethane for 15h; Ambient temperature;17%
With chloroacetic acid In xylene for 1.5h; Heating;5%

41873-61-4Relevant academic research and scientific papers

Biobased High-Performance Aromatic-Aliphatic Polyesters with Complete Recyclability

Cai, Zhongzheng,Fan, Hua-Zhong,Gong, Fu-Long,Tu, Yi-Min,Wang, Xue-Mei,Yang, Xing,Zhu, Jian-Bo

supporting information, p. 20591 - 20597 (2021/12/09)

The development of high-performance recyclable polymers represents a circular plastics economy to address the urgent issues of plastic sustainability. Herein, we design a series of biobased seven-membered-ring esters containing aromatic and aliphatic moie

Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site

Kong, Ling-Yi,Leng, Jia-Fu,Lian, Bao-Ping,Shao, Yu-Ying,Xia, Yuan-Zheng,Yin, Yong

, (2020/02/11)

A novel series of shikonin-benzo[b]furan derivatives were designed and synthesized as tubulin polymerization inhibitors, and their biological activities were evaluated. Most compounds revealed the comparable anti-proliferation activities against the cancer cell lines to that of shikonin and simultaneously low cytotoxicity to non-cancer cells. Among them, compound 6c displayed powerful anti-cancer activity with the IC50 value of 0.18 μM against HT29 cells, which was significantly better than that of the reference drugs shikonin and CA-4. What's more, 6c could inhibit tubulin polymerization and compete with [3H] colchicine in binding to tubulin. Further biological studies depicted that 6c can induce cell apoptosis and cell mitochondria depolarize, regulate the expression of apoptosis related proteins in HT29 cells. Besides, 6c actuated the HT29 cell cycle arrest at G2/M phase, and influenced the expression of the cell-cycle related protein. Moreover, 6c displayed potent inhibition on cell migration and tube formation that contributes to the antiangiogenesis. These results prompt us to consider 6c as a potential tubulin polymerization inhibitor and is worthy for further study.

INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

-

Paragraph 0547; 0558, (2018/04/27)

The present disclosure discloses compounds capable of modulating the activity of α- amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.

Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics

Hussein, Waleed M.,Feder, Daniel,Schenk, Gerhard,Guddat, Luke W.,McGeary, Ross P.

, p. 462 - 479 (2018/08/21)

Purple acid phosphatases (PAPs) are metalloenzymes that catalyse the hydrolysis of phosphate esters under acidic conditions. Their active site contains a Fe(III)Fe(II) metal centre in mammals and a Fe(III)Zn(II) or Fe(III)Mn(II) metal centre in plants. In humans, elevated PAP levels in serum strongly correlate with the progression of osteoporosis and metabolic bone malignancies, which make PAP a target suitable for the development of chemotherapeutics to combat bone ailments. Due to difficulties in obtaining the human enzyme, the corresponding enzymes from red kidney bean and pig have been used previously to develop specific PAP inhibitors. Here, existing lead compounds were further elaborated to create a series of inhibitors with Ki values as low as ~30 μM. The inhibition constants of these compounds were of comparable magnitude for pig and red kidney bean PAPs, indicating that relevant binding interactions are conserved. The crystal structure of red kidney bean PAP in complex with the most potent inhibitor in this series, compound 4f, was solved to 2.40 ? resolution. This inhibitor coordinates directly to the binuclear metal centre in the active site as expected based on its competitive mode of inhibition. Docking simulations predict that this compound binds to human PAP in a similar mode. This study presents the first example of a PAP structure in complex with an inhibitor that is of relevance to the development of anti-osteoporotic chemotherapeutics.

HEMIAMINAL-TAG FOR PROTEIN LABELING AND PURIFICATION

-

Page/Page column 15, (2018/06/30)

The invention pertains to the synthesis, isolation, and characterization of hemiaminal for selective labeling of peptides, proteins, antibodies, and organic fragments with -C(=0) CH2NH2 and derivatives with -CH2NH2 group over -C(=0) CHRNH2 group (where R≠H). The invention also pertains to the method of single-site immobilization of proteins through N-terminus Gly on solid phase. The invention includes late-stage tagging of N-terminus Gly with an affinity tag, 19F NMR probe, and a fluorophore and a method for metal-free protein purification and isolation of analytically pure proteins.

In situ Bronsted-Lowry acid catalyzed syntheses, characterization, single crystal XRD, electronic spectral-, DPPH radical scavenging-, and DNA protection studies of aryl-3,3′-bis(indolyl)methanes

Suresh Kumar,Antony Muthu Prabhu,Seethalaksmi,Bhuvanesh,Kumaresan

supporting information, p. 249 - 256 (2014/01/23)

A series of novel aryl-3,3′-bis(indolyl)methanes (BIMs) were synthesized using indole and formylphenoxyaliphatic acid(s) in water in the absence of any catalyst. The formylphenoxyaliphatic acid behaves as an in situ Bronsted-Lowry acid catalyst in water. UV-Visible and fluorescence spectra of the compounds were recorded in selected solvents. The gas phase geometry optimization of the compounds were achieved using DFT calculations at B3LYP/3-21G(*) level of theory. The electronic properties, such as HOMO-LUMO energies were calculated using the above method based on the optimized structure. Compounds have better DPPH radical scavenging activity and reduction of oxidative damage of DNA.

Biotransformation of new racemic (R,S)-5-benzylhydantoin derivatives by D-hydantoinases from adzuki bean

Latacz, Gniewomir,Kie?-Kononowicz, Katarzyna

, p. 117 - 124 (2014/04/17)

In the present work the scope of D-hydantoinase enzyme application was increased towards new racemic (R,S)-5-benzylhydantoin derivatives. Five new substrates for the D-hydantoinase (R,S)-5-(3′-carboxybenzyl)hydantoin, (R,S)-5-(4′-carboxybenzyl)hydantoin, (R,S)-5-(2′-carbomethoxybenzyl) hydantoin, (R,S)-5-(3′-carbomethoxybenzyl)hydantoin and (R,S)-5-(4′(4-ethoxycarboxy)propoxybenzyl)hydantoin were synthesised and converted using a two-step hydantoinase process into their corresponding D-phenylalanine derivatives. In this study two D-hydantoinases from Vigna angularis (adzuki bean) obtained from commercial sources were used: pure, isolated directly from Vigna angularis (V.a.D-HYD) 494 U/g and immobilised, recombinant, cloned and expressed in Escherichia coli (rD-HYD) 53.1 U/g. The results obtained showed that the examined enzymes catalysed hydrolysis of all new substrates into their corresponding N-carbamoyl-D-phenylalanine derivatives. High enantiomeric purities of the resulting D-phenylalanine derivatives were also determined. However, very low conversion yields of (R,S)-5-(3′- carboxybenzyl)hydantoin and (R,S)-5-(2′-carbomethoxybenzyl)hydantoin to corresponding N-carbamoyl-D amino acid were observed. Three D-phenylalanine derivatives: 4-carboxy-D-phenylalanine, 3-carbomethoxy-D-phenylalanine and 4-carbopropoxy-D-phenylalanine were obtained and isolated from the reaction mixtures using ion-exchange chromatography.

Small molecule mimetics of an interferon-α receptor interacting domain

Bello, Angelica M.,Wei, Lianhu,Majchrzak-Kita, Beata,Salum, Noruê,Purohit, Meena K.,Fish, Eleanor N.,Kotra, Lakshmi P.

, p. 978 - 985 (2014/02/14)

Small molecules that mimic IFN-α epitopes that interact with the cell surface receptor, IFNAR, would be useful therapeutics One such 8-amino acid region in IFN-α2, designated IRRP-1, was used to derive 11 chemical compounds that belong to 5 distinct chemotypes, containing the molecular features represented by the key residues Leu30, Arg33, and Asp35 in IRRP-1 Three of these compounds exhibited potential mimicry to IRRP-1 and, in cell based assays, as predicted, effectively inhibited IFNAR activation by IFN-α Of these, compound 3 did not display cell toxicity and reduced IFN-α- inducible STAT1 phosphorylation and STAT-DNA binding Based on physicochemical properties' analyses, our data suggest that moieties with acidic pKa on the small molecule may be a necessary element for mimicking the carboxyl group of Asp35 in IRRP-1 Our data confirm the relevance of this strategy of molecular mimicry of ligand-receptor interaction domains of protein partners for small molecule drug discovery

An efficient one pot syntheses of aryl-3,3′-bis(indolyl)methanes and studies on their spectral characteristics, DPPH radical scavenging-, antimicrobial-, cytotoxicity-, and antituberculosis activity

Suresh Kumar,Kumaresan,Antony Muthu Prabhu,Bhuvanesh,Seethalakshmi

, p. 254 - 263 (2013/02/23)

An efficient one-pot syntheses of aryl-3,3′-bis(indolyl)methanes (BIMs) from indole/2-methylindole and formylphenoxyaliphatic acid(s) is described. Esterification of carboxylic acid and aromatic electrophilic substitution reactions are achieved simultaneous in the presence of potash alum as a catalyst. This catalyst could be recovered and reused without substantial loss in its catalytic activity and the methodology could be applied on a range of closely related substrates. The solvation characteristics in ground and excited states of the compounds by monitoring the absorbance and fluorescence band maxima have been studied. The fluorescence studies in protic and aprotic solvents were rationalized on the basis of solute-solvent interaction and substituents effect on these photophysical processes analyzed. The compounds prepared showed efficient antimicrobial effect against human pathogens, cytotoxicity against A431 cell line, and DPPH radical scavenging effect. Single crystal XRD studies have been carried out for a few compounds synthesized in this work.

Potash alum [KAL(SO4)2.12H2O] catalysed esterification of formylphenoxyaliphatic acids

Shunmugadhas, Ganesan,Kumar, Suresh,Kumaresan, Sudalaiandi

, p. 857 - 863,7 (2020/09/09)

A convenient and clean procedure for esterification is reported. Direct condensation of formylphenoxyaliphatic acids with low to high boiling alcohols catalysed by potash alum gave moderate to good yields. This catalyst could be recovered and reused without substantial loss in its catalytic activity and the methodology could be used for a range of closely related substrates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 41873-61-4